Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis.

Medicine - 22 May 2026

Du Wenzhi, Li Dazheng, Li Na, Zhang Wenxiu, Wang Jianning, Wang Tianyi, Zeng Yong

Abstract excerpt

Atherosclerosis is a leading cause of cardiovascular diseases, necessitating the identification of novel therapeutic targets. By utilizing Mendelian randomization, the aim is to identify potential drug targets for the treatment of atherosclerosis. Using results from genomewide association studies and protein quantitative trait loci data, we genetically identified causal effects of levels of several circulating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Lipoprotein(a)

Share to Mendelian Randomization Analysis

Share to Proprotein Convertase 9

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 42175412
DOI: 10.1097/MD.0000000000048919
PMCID: PMC13201041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis.PMID 42175412Read ↗

From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment.Semantic proximity Read ↗

From the garden to the clinic: how Mendelian randomization is shaping up atherosclerotic cardiovascular disease prevention strategies.Semantic proximity Read ↗

Target Discovery for Drug Development Using Mendelian Randomization.Semantic proximity Read ↗

Leveraging Mendelian randomization to inform drug discovery and development for ischemic strokeSemantic proximity Read ↗

Therapeutic protein targets for cardiometabolic diseases: Mendelian randomization integrating plasma proteomes with genome-wide association dataSemantic proximity Read ↗

Mendelian Randomization Studies in Atherosclerotic Cardiovascular DiseasesSemantic proximity Read ↗

Proteomic Insights into Lp(a) Cardiovascular Mechanisms: A Mendelian Randomization StudySemantic proximity Read ↗

Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease.Semantic proximity Read ↗

Genetic causal association between lipidomic profiles, inflammatory proteomics, and aortic stenosis: a Mendelian randomization investigation.Semantic proximity Read ↗

Mendelian Randomization in Stroke: A Powerful Approach to Causal Inference and Drug Target ValidationSemantic proximity Read ↗

Factorial Mendelian randomization of lipoprotein (a) lowering, low-density lipoprotein cholesterol lowering, and lifestyle improvements: joint associations with cardiovascular risk.Semantic proximity Read ↗

Mendelian Randomization: Principles and its usage in Lp(a) research.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.